
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BSEM market cap is 202.77M. The company's latest EPS is USD -0.5208 and P/E is -23.91.
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 2.63M | 2.52M | 4.34M | 6.88M | 16.69M |
Operating Income | -5.68M | -1.84M | -1.43M | -4.68M | -7.78M |
Net Income | -6.34M | -2.39M | -1.37M | -7.08M | -8.48M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 3.15M | 2.67M | 2.74M | 3.47M | 14.56M |
Total Liabilities | 7.09M | 8.3M | 8.14M | 7.42M | 15.9M |
Total Equity | -3.94M | -5.63M | -5.4M | -3.95M | -1.34M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -845k | -582k | -625k | -1.64M | -3.5M |
Investing | 45k | N/A | 61k | -470k | -210k |
Financing | -235k | 542k | 804k | 573k | 3.18M |
Market Cap | 202.77M |
Price to Earnings Ratio | -23.91 |
Price to Sales Ratio | 12.15 |
Price to Cash Ratio | 846.94 |
Price to Book Ratio | -150.87 |
Dividend Yield | - |
Shares Outstanding | 16.29M |
Average Volume (1 week) | 71.64k |
Average Volume (1 Month) | 82.06k |
52 Week Change | 46.13% |
52 Week High | 28.2565 |
52 Week Low | 6.77 |
Spread (Intraday) | 1.23 (9.47%) |
Company Name | BioStem Technologies Inc (PK) |
Address |
2836 center prt circle pompano beach, florida 33604 |
Website | https://www.biostemtech.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions